FitLife Brands, Inc. Q4 2025 Earnings Call Summary

FitLife Brands, Inc. hosted an earnings call on April 1, 2026, to discuss financial results for the fiscal year ended December 31, 2025. The fourth quarter included the first full financial results from the acquisition of Irwin Naturals on August 8, 2025. For the full year 2025, Legacy FitLife (excluding MRC and MusclePharm) saw organic revenue growth of approximately 6%, with online revenue increasing by 16%. MusclePharm grew 5% organically, while MRC revenue declined 15%. Irwin Naturals, after normalizing for the discontinuation of Costco U.S. and CBD products and the bankruptcy of Rite Aid, showed flat revenue from 2024 to 2025. In Q4 2025, total revenue increased by 73% to $25.9 million, primarily due to the Irwin acquisition, though Legacy FitLife experienced weakness. Gross margin decreased to 37.0% (excluding inventory step-up amortization) from 41.4% in Q4 2024, largely due to the lower historical margins of Irwin. Adjusted EBITDA increased by 14% to $3.5 million. The company is focusing on five priorities to address recent performance, including improving Irwin's supply chain, focusing on new product development for Irwin, driving off-Amazon demand generation, leveraging Irwin's sales team for cross-selling, and operating more efficiently.